Steven Cohen's VKTX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 473,308 shares of Viking Therapeutics, Inc. (VKTX) worth $18.46 M, representing 0.02% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in VKTX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 473,308 shares. Largest reduction occurred in Q2 2023, reducing 789,378 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Viking Therapeutics (VKTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Viking Therapeutics (VKTX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +473,308 | New Buy | 473,308 | $39.01 |
| Q1 2026 | -313,492 | Sold Out | 0 | $0.00 |
| Q4 2025 | +313,492 | New Buy | 313,492 | $35.18 |
| Q3 2025 | -39,930 | Sold Out | 0 | $0.00 |
| Q2 2025 | +39,930 | New Buy | 39,930 | $26.50 |
| Q2 2024 | -133,990 | Sold Out | 0 | $0.00 |
| Q1 2024 | +133,990 | New Buy | 133,990 | $82.00 |
| Q3 2023 | -303,957 | Sold Out | 0 | $0.00 |
| Q2 2023 | -789,378 | Reduce 72.20% | 303,957 | $16.21 |
| Q1 2023 | -12,265 | Reduce 1.11% | 1.09 M | $16.65 |
| Q4 2022 | +1.11 M | New Buy | 1.11 M | $9.40 |
Steven Cohen's Viking Therapeutics Investment FAQs
Steven Cohen first purchased Viking Therapeutics, Inc. (VKTX) in Q4 2022, acquiring 1,105,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Viking Therapeutics, Inc. (VKTX) for 11 quarters since Q4 2022.
Steven Cohen's largest addition to Viking Therapeutics, Inc. (VKTX) was in Q4 2022, adding 1,105,600 shares worth $10.39 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 473,308 shares of Viking Therapeutics, Inc. (VKTX), valued at approximately $18.46 M.
As of the Q2 2026 filing, Viking Therapeutics, Inc. (VKTX) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Viking Therapeutics, Inc. (VKTX) was 1,105,600 shares, as reported at the end of Q4 2022.